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Summary
Programmed cell death is a necessary part of development and tissue homeostasis enabling the
removal of unwanted cells. In the setting of infectious disease, cells that have been commandeered
by microbial pathogens become detrimental to the host. When macrophages and dendritic cells are
compromised in this way, they can be lysed by pyroptosis, a cell death mechanism that is distinct
from apoptosis and oncosis/necrosis. Pyroptosis is triggered by Caspase-1 after its activation by
various inflammasomes, and results in lysis of the affected cell. Both pyroptosis and apoptosis are
programmed cell death mechanisms, but are dependent on different caspases, unlike oncosis.
Similar to oncosis, and unlike apoptosis, pyroptosis results in cellular lysis and release of the
cytosolic contents to the extracellular space. This event is predicted to be inherently inflammatory,
and additionally coincides with IL-1β and IL-18 secretion. We discuss the role of distinct
inflammasomes, including NLRC4, NLRP3 and AIM2, as well as the role of the ASC focus in
Caspase-1 signaling. We further review the importance of pyroptosis in vivo as a potent
mechanism to clear intracellular pathogens.
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Introduction
In this review we discuss pyroptosis, which is defined as Caspase-1 dependent programmed
cell death, resulting in rapid lysis of the affected cell. We begin by placing pyroptosis in the
context of other cell death mechanisms.
Cell death was classically viewed as either apoptosis or necrosis, a mechanistically binary
perspective that is now known to be an oversimplification. In 1994 E. Faber wrote “there is
no field of basic cell biology and cell pathology that is more confusing and more
unintelligible than is the area of apoptosis versus necrosis” (1), a view that only seems truer
17 years later. The use of the term necrosis to refer both to a specific type of cell death, and
to the pathologic changes at the tissue level after cell death has generated some confusion in
the field. The term oncosis has been suggested as an alternative to “necrotic cell death” to
refer to cell death that involves cellular swelling, typically caused by ischemia or other
insults which impaired cellular ATP generation (2). This preserves the term “necrosis” for
the description of histopathology resulting from multiple cell death mechanisms. Although
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the term oncosis has not been widely used, it is perhaps a more accurate term in discussing
cell death, and we will use it herein.
Cell death can be broadly categorized by describing the initiating events, the intermediate
changes, the terminal cellular events, and its effect on tissue (see Table 1 for a comparison
of apoptosis, pyroptosis, and oncosis). Each cell death pathway may be distinguished on the
basis of these four categories. In addition to apoptosis and oncosis, several other forms of
cell death have been described, including pyroptosis (3), autophagic cell death (4), NETosis
(5), necroptosis (6), mitotic catastrophe (7), and lysosomal membrane permeabilization (8).
Most of these modalities have specific initiation events in vitro, and some, but not all, have
well defined roles in vivo.
Initiating events in cell death may be programmed, meaning that specific dedicated signaling
pathways are involved (as in apoptosis and pyroptosis), or accidental/non-programmed (as
in oncosis), in which specific signaling events are not required. Apoptosis was once
synonymous with programmed cell death, but now many other forms of programmed cell
death have been described (4). It can be initiated by a variety of stimuli arising from
receptors on the cell surface (extrinsic pathway) or from detection of events within the cell
(intrinsic pathway). Pyroptosis is initiated by a variety of stimuli, including cytosolic
flagellin or T3SS rod proteins, phagocytosis of crystals, and opening of pores in the
membrane. Oncosis results from chemical, thermal, or radiation damage to cells that cause
disruption of cellular processes beyond the point of repair. Such damaged cells will
inevitably die. The lines between programmed and non-programmed cell death can become
blurred in cases of lower intensity insults, in which cellular enzymatic activities can
exacerbate the damage and contribute to cell death. For example, oxidative stress can cause
lysosomal disruption and the release of proteases to the cytosol, resulting in proteolysis of
cytosolic proteins that induces death. This initiating event could be considered either
accidental release of toxic substances, or a pre-set mechanism to detect cellular damage and
initiate a cell death response (8).
Intermediate changes observed upon examination of dying cells using bright field, confocal,
or electron microscopy reveal differences between apoptotic and necrotic cell death.
Apoptosis results in characteristic morphologic changes, including cell shrinkage, nuclear
condensation, nuclear fragmentation, and membrane blebbing. In contrast, oncosis results in
morphology characterized by cellular rounding, cytoplasmic swelling, dilation of cellular
organelles, the absence of chromatin condensation, and disorganized dismantling of
intracellular contents (2). While the apoptotic morphology still holds as a specific marker for
apoptosis, the necrotic morphology can be observed in several mechanistically distinct
forms of cell death.
The terminal cellular event can be characterized as non-lytic or lytic (4). These two
categories are intimately linked to the intermediate morphologic changes. Oncosis and
pyroptosis result in the lysis of the cell and release of cytosolic contents. Apoptosis ends
when cells segment into smaller apoptotic bodies, in a process called blebbing. Apoptotic
bodies are membrane bound and contain the contents of the nucleus and cytoplasm, which
can be phagocytosed and degraded. Cytosolic contents are not normally released, but if
apoptotic bodies are not cleared they will lyse in a process called secondary necrosis (2).
Finally, the effects of cellular death at the tissue level can be considered. Typically apoptosis
is non-inflammatory, meaning that neutrophils are not recruited and adaptive immune
responses are not initiated. Macrophages migrate towards apoptotic bodies, attracted by
“find-me” signals (9), but they do not promote additional inflammatory changes. Apoptotic
bodies are cleared without damage to the tissue unless the amount of apoptotic bodies
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exceeds the removal capacity of the local or recruited macrophages, resulting in secondary
necrosis (2). In contrast, oncosis and pyroptosis are inflammatory. Several small molecules
and proteins that are normally confined within cells are detected by specific receptors that
induce a response characterized by the classical signs of inflammation at the tissue level:
rubor (redness), dolor (pain), calor (heat), and tumor (swelling). In areas of extensive cell
death, tissue necrosis, also called coagulation necrosis, occurs.
Caspase activation
Caspases play central roles in initiating apoptosis and pyroptosis, but are not involved in
other programmed cell death. They are proteases that use active site cysteine residues to
cleave target proteins after aspartate residues. Caspases exist in inactive pro forms in the
cytosol, and are activated by proteolytic cleavage by other caspases. For example, murine
Caspase-1 can be cleaved at six sites: cleavage at D103 and/or D122 removes the CARD
domain from the proteolytic domains while cleavage at D296, D308, D313 and D314
separates the p10 and p20 catalytic domain fragments (10). These proteases are broadly
classified as apoptotic (Caspase-2, 3, 6, 7, 8, 9, 10) or inflammatory (Caspase-1, 4, 5, 12)
(11).
Apoptotic caspases are either initiators or effectors (11). Initiator caspases respond to a
specific initiating event that activates the intrinsic or extrinsic pathway. Molecular events
occurring inside the cell trigger the intrinsic pathway. For example, DNA damage induces
PIDD/RAIDD oligomerization that activates Caspase-2. Alternatively, cytochrome C
released from damaged mitochondria is detected by APAF-1, which activates Caspase-9.
The extrinsic pathway is triggered by ligation of transmembrane receptors, including TNF
receptor, Fas, and TRAIL receptor, resulting in activation of Caspase-8 or -10. Both the
intrinsic and extrinsic pathways activate the effector caspases, Caspase-3, -6, and/or -7,
which cleave the target molecules that promote apoptosis (12).
In contrast to the apoptotic caspases, initiator and effector functions have not been defined
for the inflammatory caspases. Caspase-1 is the best-described inflammatory caspase. It
processes the cytokines IL-1β and IL-18 and induces pyroptotic cell death. While Caspase-1
was once thought to also process IL-33, this is no longer believed to be the case(13).
Caspase-4 and -5 are also inflammatory caspases, though their functions are less well
defined (Caspase-5 is not present in mice, and murine Caspase-4 is also known as
Caspase-11). Caspase-12 exists in both truncated and full-length alleles in humans and as a
full-length caspase in rodents. The full-length alleles exert inhibitory effects on Caspase-1
(14). Caspase-4 is not required for pyroptosis (10), nor is there any evidence that Caspase-12
plays a role.
Inflammasomes and Apoptosomes
Caspase-9 and Caspase-1 are activated by Nod-like receptors (NLRs) forming the
apoptosome and inflammasome, respectively. NLRs are composed of a signaling domain
(typically a CARD or Pyrin domain), a nucleotide-binding oligomerization domain (NOD),
and a sensor domain (WD40 repeat domain or leucine-rich repeat domain, LRR). The
mechanisms of caspase activation were first described for the NLR family member APAF-1.
APAF-1 contains a CARD signaling domain and a WD40 repeats domain. In the inactive
state, the WD40 repeats interact with and inhibit the NOD domain. When the WD40 repeats
bind to cytochrome C, the NOD domain is released, permitting oligomerization of seven
APAF-1 monomers into a hub like structure called the apoptosome. The APAF-1 CARD
domain recruits pro-Caspase-9 via homotypic interaction with the Caspase-9 CARD domain.
This activates Caspase-9 proteolytic activity permitting one Caspase-9 molecule to cleave its
neighbor into the active form (15).
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Caspase-1 activation is regulated by protein complexes termed inflammasomes, which are
analogous to the apoptosome. Two types of NLR inflammasomes are known. NLRC4 and
murine NLRP1b contain CARD domains that directly interact with the Caspase-1 CARD,
making these inflammasomes directly analogous to the APAF-1 apoptosome (16). In
contrast, NLRP3 contains a Pyrin signaling domain instead of a CARD domain. The Pyrin
domain of NLRP3 binds the Pyrin domain of the adaptor protein ASC. ASC (also known as
PYCARD) is composed of only a Pyrin and a CARD domain. ASC recruits Caspase-1 via
CARD-CARD interactions (17). In an added wrinkle, AIM2 also forms an inflammasome.
However, AIM2 is not an NLR. It contains a HIN200 domain and a Pyrin domain that
recruits ASC and activates Caspase-1 (18).
Caspase-1 becomes activated in response to numerous stimuli that are detected through
distinct inflammasomes. NLRC4 responds to cytosolic flagellin or T3SS rod proteins (16,
19), murine NLRP1b responds to anthrax lethal toxin (20), AIM2 responds to cytosolic
DNA (18), and NLRP3 responds to a variety of agonists including crystals (17). Each of
these sensors triggers pyroptosis (21).
Pyroptosis
Pyroptosis was first described in 1992 in macrophages infected with Shigella flexneri (22),
and shortly thereafter a similar phenotype was observed after infection with S. typhimurium
(23, 24). It was termed “apoptosis” based on morphologic changes (apparent blebbing) and
the presence of DNA fragmentation, chromatin condensation, and the requirement for
Caspase-1 (23–27). At the time, caspase dependence was a hallmark of apoptotic cell death.
Pyroptosis was subsequently shown to be distinct from apoptosis (28, 29), and the name was
coined in 2001 (30). “Pyro“ originates from the Greek word for fire in reference to the
involvement of Caspase-1 and IL-1β in fever and inflammation. “Ptosis” (silent “p”) comes
from the Greek word for falling as used for other forms of cell death. To date, pyroptosis has
only been described in macrophages and dendritic cells (21, 31) though there is some
evidence of Caspase-1 activity in other cell types (32).
Both pyroptosis and apoptosis are forms of programmed cell death that require specific
Caspase activity. Unlike apoptosis, pyroptosis occurs after Caspase-1 activation, and does
not involve apoptotic caspases (26, 28, 33, 34). In addition, target proteins such as PARP1
and ICAD, which are characteristically cleaved during apoptosis, remain intact during
pyroptosis (28, 35, 36). Finally, apoptosis proceeds normally in the absence of Caspase-1
(37, 38). Thus, apoptosis and pyroptosis are distinct forms of programmed cell death.
Several features of pyroptosis seem to overlap with apoptosis, but upon further investigation
are found to be distinct. First, during pyroptosis, cells incur DNA damage (22) and become
positive in the TUNEL assay (23, 28). However, the nuclear morphology of pyroptotic cells
is distinct from apoptotic cells (28, 29), and DNA laddering is not necessarily seen (29). In
apoptosis, chromatin undergoes pyknosis, the irreversible condensation of chromatin that
localizes to the nuclear membrane (margination). This creates curved half-moon profiles of
pyknotic chromatin. The nucleus then breaks up in the process of karyorrhexis (2). In
contrast examination of the nucleus in pyroptotic cells reveals chromatin condensation, but
the nucleus remains intact and karyorrhexis does not occur (22, 29).
A second feature that is shared between pyroptosis and apoptosis is positive staining with
annexin V. Annexin V binds phosphatidyl serine that is normally restricted to the inner
leaflet of the cell membrane. During apoptosis, phosphatidyl serine translocates to the outer
leaflet, resulting in positive cell surface staining with annexin V. This discriminates
apoptotic from live cells (39). During pyroptosis, pores open in the cell membrane,
permitting annexin V to enter the cell and stain the inner leaflet of the membrane. In
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contrast, membrane impermeant dyes such as 7-aminoactinomycin (7-AAD) or propidium
iodide (PI) stain pyroptotic cells by entering through the pores, but do not stain apoptotic
cells (28, 31, 36, 40). An additional consequence of pore formation in pyroptosis is cellular
swelling (36), which can be blocked by extracellular osmoprotectants, or by extracellular
glycine (28, 36). Conversely, apoptotic cells shrink. Thus, the mechanisms resulting in
positive annexin V staining are different between apoptosis and pyroptosis.
A third apparent similarity between pyroptosis and apoptosis is the formation of spherical
membrane bound structures. During apoptosis, the cell blebs, partitioning itself into
spherical membrane bound structures known as apoptotic bodies (2). During pyroptosis,
increased osmotic pressure results in large spherical protrusions of the membrane as it rips
away from the cortical cytoskeleton. Because electron micrographs of the protrusions
revealed spherical structures, they were initially thought to be apoptotic blebs (22, 23).
However, continued rapid swelling of these protrusions causes coalescence and rupture. This
results in the release of cytosolic contents to the extracellular space, commonly measured by
assaying for lactate dehydrogenase release (28). This does not occur during apoptosis, since
apoptotic bodies are cleared by phagocytosis.
Potential cross-talk between pyroptosis and other cell death pathways
It is possible that there is some cross activation of apoptotic caspases downstream of
Caspase-1. Caspase-1 can proteolytically process the apoptotic effector Caspase-7, but not
Caspase-3 (34). This may have effects during Legionella infection or septic shock (41, 42).
However, since pyroptosis occurs more rapidly than apoptosis, and since Caspase-7 is not
required for pyroptosis (34), the physiologic relevance of this processing event remains to be
further elucidated. Perhaps in cell types that express Caspase-1 but do not undergo
pyroptosis, such as keratinocytes (32), Caspase-1 activation results in apoptosis via
Caspase-7. This would be predicted to result in a slower and less inflammatory clearance
mechanism to remove the affected cells.
Further cross talk may arise at the agonist level. LPS or S. typhimurium infection has been
shown to activate Caspase-3 either independent of Caspase-1 (34) or dependent on
Caspase-1 (33). However, we do not observe Caspase-3 activation after LPS stimulation or
S. typhimurium infection, and find macrophages to be non-apoptotic and viable after
overnight stimulation with LPS or other TLR agonists (Miao and Aderem, unpublished
results). Thus the role of Caspase-3 after LPS or Salmonella infection remains to be further
elucidated.
In the absence of Caspase-1, alternate cell death pathways may compensate for the lack of
pyroptosis. Casp1−/− macrophages infected with S. typhimurium die via alternate cell death
pathways that are kinetically slower than pyroptosis. Caspase-2-dependent apoptosis (33)
and autophagic cell death (43) have both been implicated as alternate cell death pathways in
Casp1−/− macrophages.
Differential Caspase-1 subcellular localization for pyroptosis and cytokine
processing
The adaptor protein ASC plays a critical role in connecting pyrin domain connecting
inflammasomes (such as NLRP3 and AIM2) to Caspase-1 (44–46). At its simplest level,
ASC docks onto the inflammasome hub via pyrin-pyrin interactions, then recruits Caspase-1
via CARD-CARD interactions. Thus, an NLRP3 inflammasome hub containing seven
NLRP3 monomers (by analogy to APAF-1) could recruit seven ASC adaptors and seven
pro-Caspase-1 proteins. However, the actual signaling complex inside a cell is more
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complex than this. ASC can interact with itself, recruiting additional ASC molecules via
pyrin-pyrin and CARD-CARD interactions (47). This creates a cascade effect where all of
the ASC within a cell is recruited to a single subcellular location, which has been called the
“ASC focus” or “ASC speck” (10, 48, 49). Because ASC is required for pyroptosis
induction via NLRP3 and AIM2, the ASC focus has also been called the “pyroptosome”
(50), however given recent results discussed below this term should be discontinued (ASC is
not required for pyroptosis in all cases and is more prominently required for cytokine
processing). The ASC focus is a large subcellular structure that can be visualized by
confocal fluorescent microscopic staining for ASC (Fig. 1), and has a central core with
apparent dendrites extending from the center (10, 45, 48–51). The ASC focus recruits
Caspase-1, resulting in its activation and proteolysis of pro-Caspase-1 to the mature form via
neighboring activated Caspase-1 proteins (45). Caspase-1 proteolysis is required to enable it
to cleave pro-IL-1β (10) (Fig. 1). IL-1β is also recruited to the foci via interactions with
Caspase-1. IL-1β recruitment is unaffected by the Caspase-1 inhibitor zYVAD-FMK, but
was ablated in Casp1−/− macrophages (49). This indicates that the ASC focus recruits and
activates Caspase-1 via autoproteolysis, and that Caspase-1 processes pro-IL-1β within the
ASC focus.
In the case of CARD containing inflammasomes, for example NLRC4, the CARD domain
can interact directly with Caspase-1 (52), apparently obviating the need for ASC (Fig. 1).
However, NLRC4 additionally recruits ASC via CARD-CARD interactions (53) and
induces the formation of ASC foci. Thus, NLRC4 (and presumably other CARD containing
inflammasomes) can activate Caspase-1 via ASC-dependent and ASC-independent
mechanisms. Study of these two mechanisms has recently led to insights into distinct
mechanisms for cytokine processing and pyroptosis. After NLRC4 activation, the ASC
focus forms and is required for efficient processing and secretion of pro-IL-1β (54).
However, Asc−/− macrophages are competent to undergo pyroptosis after activation of
NLRC4 (10, 54–59)(and T Bergsbaken and BT Cookson; and C Case and C Roy, personal
communication). Thus, the ASC focus is the processing center for IL-1β while it was not
required for pyroptosis. Instead, diffuse cytosolic activated Caspase-1 is observed and
appears to be the form of Caspase-1 mediating pyroptosis (10) (and T Bergsbaken and BT
Cookson; and C Case and C Roy, personal communication). This diffuse Caspase-1 requires
catalytic activity, but does not require processing to trigger pyroptosis (10) (Fig. 1). This
suggests that diffuse cytosolic NLRC4 inflammasomes activate Caspase-1 via
conformational changes, and that these conformational changes do not require proteolysis.
Perhaps pro-Caspase-1 undergoes conformational changes while tethered to the
inflammasome, and that the protein remains tethered to the diffuse cytosolic inflammasome.
Alternately, a conformational change may occur, such as dimerization, releasing activated
(but not proteolyzed) Caspase-1 into the cytosol. Thus, NLRC4, and presumably other
CARD-containing inflammasomes, can form two functional inflammasomes that are
spatially distinct and that have differential processing requirements. The first is simpler and
contains only NLRC4 and Caspase-1, is located diffusely in the cytosol, and results in
pyroptosis. In the second, NLRC4 triggers formation of the ASC focus, which recruits and
activates Caspase-1, resulting in IL-1β (and presumably IL-18) processing and secretion.
These two distinct inflammasomes may compete with each other within the cell, as Asc−/−
macrophages form pyroptosis-associated pores more rapidly than WT cells (C Case and C
Roy, personal communication), suggesting a dynamic interplay between cytokine processing
and pyroptosis.
Given this dual inflammasome paradigm for NLRC4, one might think that NLRP3 and
AIM2 would not induce pyroptosis because they cannot directly interact with Caspase-1.
However, NLRP3 and AIM2 do induce pyroptosis, and they do so through ASC (60–66).
This is distinct from NLRC4, which induces pyroptosis independent of ASC. Interestingly,
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the requirement for proteolytic processing of pro-Caspase-1 is the same between pyrin-
containing and CARD-containing inflammasomes. In both cases pro-Caspase-1 must be
processed to efficiently cleave pro-IL-1β, but processing is not required for pyroptosis (10).
There are several potential mechanisms whereby this may occur. The ASC foci may release
activated Caspase-1 to the cytosol. Alternately, the Caspase-1 targets that promote
pyroptosis may diffuse to the ASC foci, where they are cleaved. Both of these mechanisms
would result in slower onset pyroptosis for NLRP3/AIM2 than NLRC4 inflammasomes.
Future work in the field will reveal whether these or alternate mechanisms are at work for
pyrin-containing inflammasomes.
Role of pyroptosis in vivo
Pyroptosis has been well defined in vitro, with innumerable reports examining how the
inflammasome triggers pyroptosis in cultured macrophages. However, until recently its
relevance in vivo was unclear. There were some reports suggested that Caspase-1 may exert
effects independent of IL-1β and IL-18 secretion, indirectly suggesting a role for pyroptosis
in vivo, but not investigating a role for pyroptosis directly. Recently we provided evidence
that pyroptosis occurs in vivo, and that it is an exquisitely potent innate immune effector
mechanism used to clear intracellular pathogens. We will summarize these studies in this
section.
Casp1−/− mice infected with Francisella novicida (also called F. tularensis subspecies
novicida) show increased bacterial burdens compared to wild type mice (67). Administration
of both IL-1β and IL-18 neutralizing antibodies into WT mice increased their susceptibility,
but did not fully recapitulate the phenotype of Casp1−/− mice. This suggested that the
cytokines play a role but that they do not account for the complete phenotype of Casp1−/−
mice. The authors hypothesized that pyroptotic cell death may contribute to control of F.
novicida, although the occurrence of pyroptosis in vivo and its mechanistic contribution to
bacterial clearance was not examined (67). It is also possible that the neutralizing antibodies
were not fully penetrant; in this regard results using Il1b-Il18DKO mice will be informative
in future studies.
A model of sepsis revealed a role for Caspase-1, and this was independent of IL-1β and
IL-18. Sarkar et al. used intraperitoneal injection of 5 × 108 cfu/kg of Escherichia coli
BL21(DE3) into mice (68). In this model, WT mice succumb to the infection while Casp1−/−
mice are resistant. In contrast, Il1b-Il18DKO mice responded similar to WT mice, suggesting
a role for pyroptosis. In this report, B cell apoptosis was implicated on the basis of
histological appearance of apoptotic bodies in the white pulp that stain for CD79. This was
not observed in Casp1−/− mice or mice treated with zVAD-fmk, a generic caspase inhibitor
(68). To date it is unclear whether Caspase-1 plays a role in B cells, thus, the observed B cell
death may be due to the activity of Caspase-1 within the B cells, or to the activity of
Caspase-1 within neighboring phagocytes. Thus, this cell death may have been pyroptosis in
B cells, or apoptosis in B cells secondary to pyroptosis in splenic macrophages.
We recently demonstrated that bacterial burden in the draining lymph node after both
Legionella pneumophila and Burkholderia thailandensis intraperitoneal infection also
showed Caspase-1 dependence that was not replicated in Il1b-Il18DKO mice, again
suggesting a role for pyroptosis in vivo. However, we did not directly investigate a role for
pyroptosis in these models (59).
These above reports provided some evidence that Caspase-1 has effects in vivo that cannot
be accounted for by IL-1β and IL-18, but did not investigate whether these effects could be
attributed to pyroptosis. We recently showed a role for pyroptosis in clearing bacteria in
vivo (Fig. 2) by studying the evasion mechanisms that are required for S. typhimurium
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virulence. S. typhimurium effectively evade detection by the inflammasome by repressing
flagellin expression and expressing a T3SS rod protein that is not detected by NLRC4 (for
an extensive review on S. typhimurium detection by and evasion of the inflammasome see
(69)). We engineered S. typhimurium strains that persistently express flagellin or an NLRC4
detected T3SS rod protein, and found that in both cases the bacteria were rendered severely
attenuated via NLRC4-dependent Caspase-1 activation (19, 59). Protection was not
observed in Nlrc4−/− or Casp1−/− mice, but surprisingly, was still observed in Il1b-Il18DKO
mice (59). We investigated whether pyroptosis plays a role in this clearance response. We
found that phagocytes in vivo lost membrane integrity when infected with flagellin
expressing bacteria, and that this was dependent upon NLRC4. NLRC4 dependent loss of
membrane integrity defines this cell death as pyroptotic and not oncotic. Because there was
no clear bactericidal mechanism that would result from lysing an infected cell, we
hypothesized that the bacteria were released in a viable state after pyroptosis, and were
killed by a secondary phagocyte. Indeed, after induction of pyroptosis, the bacteria were
exposed to the extracellular antibiotic gentamicin. We hypothesized that neutrophils were
the key phagocyte clearing these bacteria, and thus examined Ncf1−/− mice, which cannot
make the p47 component of the NADPH phagocyte oxidase complex. Neutrophils in these
mice have defective bactericidal activity. We found that Ncf1−/− mice failed to clear
flagellin expressing S. typhimurium. Interestingly, in Ncf1−/− mice, the bacteria were now
located predominantly in neutrophils. We concluded that macrophages undergo pyroptosis,
releasing the bacteria to the extracellular space, where they are exposed to uptake by
neutrophils (59). These data indicate that neutrophils are an important secondary phagocyte
in the clearance of bacteria released by pyroptosis and that the NADPH oxidase system is
critical to clear bacteria released by pyroptosis. These results were the first demonstration
that pyroptosis is an innate immune effector mechanism in vivo (Fig. 2). The potency of
pyroptosis in clearing infection is illustrated by the fact that it completely protects an animal
from an otherwise lethal infection.
Why does pyroptosis function in macrophages and not neutrophils? Many pathogens are
able to survive and replicate within macrophages, however very few pathogens are able to
do so in neutrophils. This is likely due to intrinsic differences between these two cell types.
Macrophages are longer lived, and have reduced microbicidal activity compared to
neutrophils, making them a more susceptible target to infection. Neutrophils, on the other
hand, are highly microbicidal, and short lived, making them poor targets for intracellular
pathogens. Interestingly, while neutrophils express Caspase-1, they did not express NLRC4
(59), suggesting that they do not undergo pyroptosis in response to flagellin or T3SS rod
protein contamination of their cytosol. It remains to be determined whether neutrophils will
undergo pyroptosis in response to other inflammasome agonists.
Concluding remarks
Pyroptosis can now be viewed as a physiologically important form of cell death, which
serves to eject intracellular pathogens from their replicative niche within macrophages.
When considering the function of Caspase-1 during infectious and inflammatory diseases,
pyroptosis should be considered as a potential mechanism along with IL-1β and IL-18
secretion. For example, resistance to influenza infection conferred by Caspase-1 is likely
primarily due to processing and secretion of IL-1β (70–74). On the other hand, Shigella
infection is controlled by Caspase-1-dependent IL-18 secretion (75). In contrast,
Burkholderia infection may be controlled primarily via pyroptosis (59). In a note of added
complexity, S. typhimurium seem to be weakly detected by the inflammasome resulting in
some protective effects from IL-18, but they effectively evade pyroptosis, and this evasion is
essential for virulence (69). Still other infections are likely to be controlled through a
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combination of the two cytokines and pyroptosis, and potentially by additional Caspase-1-
dependent effector mechanisms that are yet to be discovered.
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Figure 1. Role of ASC in cytokine processing and pyroptosis
All known inflammasomes recruit ASC, resulting in the formation of the ASC focus
(microscopic image to left showing ASC focus after L. monocytogenes infection in a
macrophage). Caspase-1 is processed in the ASC focus and cleaves pro-IL-1β and pro-IL-18
to their mature, secreted forms. CARD-containing inflammasomes, such as NLRC4, also
bind Caspase-1 independent of ASC, and this complex does not require Caspase-1
processing, and triggers pyroptosis. Pyrin-containing inflammasomes, such as AIM2 and
NLRP3, trigger pyroptosis through ASC.
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Figure 2. Pyroptosis promotes clearance of intracellular microbes
Schematic of the role of pyroptosis in clearing intracellular pathogens. Numerous pathogens
have the ability to replicate within macrophages (upper panel), eventually being released in
greater numbers. Although neutrophils have the capacity to kill many macrophage tropic
pathogens, the intracellular niche within the macrophage compartment permits these
pathogens to continue a pathogenic replicative cycle. Intracellular pathogens that are
detected by an inflammasome (lower panel) activate Caspase-1, resulting in pyroptosis. This
releases the bacteria from the macrophage prior to replication, effectively short-circuiting
the pathogenic replicative cycle. Released bacteria are thereby exposed to additional
clearance mechanisms, including phagocytosis by neutrophils.
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Table 1
Comparison of Apoptosis, Pyroptosis and Oncosis.
Apoptosis Pyroptosis Oncosis
Initiating Programmed Programmed Accidental
Signaling pathway Caspase-3/6/7 Caspase-1 Non-caspase
Terminal event Non-lytic Lytic Lytic
Effect on tissue Non-inflammatory Inflammatory Inflammatory
Cell types All Mϕ and DC All
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